The Department of Otolaryngology's commitment of resources to clinical and basic science research promises to keep the University of Kansas at the forefront of advancement for the specialty.  The department critically reviews the care and information we provide to our patients and the ways we educate future healthcare providers. We have a particular interest in healthcare delivery and patient education and hold a firm belief that the best of treatments fall short if we are not properly communicating and helping our patients understand that we are partners in their care. 

Our research endeavors continue to grow from year to year, from investigating the role of fibroblasts in head and neck cancer to leading the world's first gene therapy trial for hearing loss.  We are a department of clinician scientists and researchers, running clinical trials and outcomes research in the study of head and neck cancer, hearing and balance disorders, and sinusitis. Our desire to innovate goes beyond clinical Otolaryngology, as our faculty are active in the areas of global health, education, and change management.